Recent Advances in Liver Transplantation
A special issue of Transplantology (ISSN 2673-3943). This special issue belongs to the section "Solid Organ Transplantation".
Deadline for manuscript submissions: closed (30 June 2021)
Special Issue Editors
Interests: liver; cirrhosis; disease progression; gastroenterology; disease clinical approach; genetics
Special Issues, Collections and Topics in MDPI journals
Interests: hepatocellular carcinoma; liver transplantation; hepatic resection; prognostic algorithms; therapeutic algorithms
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear colleague,
End-stage liver disease and fulminant hepatic failure are the final stages of chronic and acute hepatic diseases, respectively. These clinical conditions are characterized by a poor 3-month survival with medical management other than liver transplant. Additionally, in the setting of hepatocellular carcinoma, liver transplantation represents, within defined criteria, the best therapeutic option.
In the last twenty years, the significant progress in the clinical management pre- and post-transplantation and the advancements in surgical techniques have guaranteed a progressive improvement of patient survival in the short and long term.
Data from the European Liver and Intestine Transplant Association show 1-year survival of 86% and 5-year survival of 74% for the liver transplants performed in European centers between 2010 and 2014.
The future challenges are to improve the referral to liver transplantation, to reduce the organ shortage in order to decrease the waiting-list mortality, and to improve the immunosuppressive strategies to minimize the side effects of long-term immunosuppressive therapy.
Dr. Flaminia Ferri
Prof. Dr. Quirino Lai
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Transplantology is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Liver transplant referral
- End-stage liver disease management
- End-stage liver disease staging
- Fulminant hepatic failure management
- Fulminant hepatic failure staging
- Evaluation for liver transplantation
- Comorbidities and listing for liver transplantation
- Hepatocellular carcinoma criteria for liver transplantation
- Side effects of immunosuppressive therapy
- Minimization of immunosuppression
